Study of Gemcitabine, Carboplatin, and Panitumumab (GCaP) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Summary

The purpose of this study is to find out if using the combination of standard chemotherapy (gemcitabine and carboplatin) plus this new drug (panitumumab) can help to shrink the tumor before the patient undergoes surgery for bladder cancer.

Timeline

Start

2013-08

Primary completion

2015-07

Completion

—

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of accrual”

Drugs

Indications